Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Gène ABCG2")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 249

  • Page / 10
Export

Selection :

  • and

PDZK1 Regulates Breast Cancer Resistance Protein in Small IntestineSHIMIZU, Takuya; SUGIURA, Tomoko; WAKAYAMA, Tomohiko et al.Drug metabolism and disposition. 2011, Vol 39, Num 11, pp 2148-2154, issn 0090-9556, 7 p.Article

Inhibitory Effects of Terpenoids on Multidrug Resistance-Associated Protein 2-and Breast Cancer Resistance Protein-Mediated TransportYOSHIDA, Naoko; TAKADA, Tappei; YAMAMURA, Yoshikazu et al.Drug metabolism and disposition. 2008, Vol 36, Num 7, pp 1206-1211, issn 0090-9556, 6 p.Article

Interactions of cyclosporin a with breast cancer resistance proteinXIA, Cindy Q; NING LIU; MIWA, Gerald T et al.Drug metabolism and disposition. 2007, Vol 35, Num 4, pp 576-582, issn 0090-9556, 7 p.Article

Antipsychotic Drugs Inhibit the Function of Breast Cancer Resistance ProteinWANG, Jun-Sheng; ZHU, Hao-Jie; MARKOWITZ, John S et al.Basic & clinical pharmacology & toxicology (Print). 2008, Vol 103, Num 4, pp 336-341, issn 1742-7835, 6 p.Article

Re-evaluation and functional classification of non-synonymous single nucleotide polymorphisms of the human ATP-binding cassette transporter ABCG2TAMURA, Ai; WAKABAYASHI, Kanako; ONISHI, Yuko et al.Cancer science. 2007, Vol 98, Num 2, pp 231-239, issn 1347-9032, 9 p.Article

Mutant Gly482 and Thr482 ABCG2 mediate high-level resistance to lipophilic antifolatesBRAM, Eran; IFERGAN, Ilan; SHAFRAN, Assaf et al.Cancer chemotherapy and pharmacology. 2006, Vol 58, Num 6, pp 826-834, issn 0344-5704, 9 p.Article

Role of Breast Cancer Resistance Protein in the Adaptive Response to CholestasisMENNONE, Albert; SOROKA, Carol J; HARRY, Kathy M et al.Drug metabolism and disposition. 2010, Vol 38, Num 10, pp 1673-1678, issn 0090-9556, 6 p.Article

ABCG2 : determining its relevance in clinical drug resistance : Transporters in CancerROBEY, Robert W; POLGAR, Orsolya; DEEKEN, John et al.Cancer metastasis reviews. 2007, Vol 26, Num 1, pp 39-57, issn 0167-7659, 19 p.Article

Identification and functional assessment of BCRP polymorphisms in a Korean PopulationSANG SEOP LEE; JEONG, Hye-Eun; YI, Joo-Mi et al.Drug metabolism and disposition. 2007, Vol 35, Num 4, pp 623-632, issn 0090-9556, 10 p.Article

Role of Cys-603 in dimer/oligomer formation of the breast cancer resistance protein BCRP/ABCG2KAGE, Kumie; FUJITA, Toshiro; SUGIMOTO, Yoshikazu et al.Cancer science. 2005, Vol 96, Num 12, pp 866-872, issn 1347-9032, 7 p.Article

The Bioflavonoid Kaempferol Is an Abcg2 Substrate and Inhibits Abcg2-Mediated Quercetin EffluxGUOHUA AN; GALLEGOS, Jorge; MORRIS, Marilyn E et al.Drug metabolism and disposition. 2011, Vol 39, Num 3, pp 426-432, issn 0090-9556, 7 p.Article

pH-Dependent Transport of Pemetrexed by Breast Cancer Resistance ProteinLI LI; YIN SHAM, Yuk; BIKADI, Zsolt et al.Drug metabolism and disposition. 2011, Vol 39, Num 9, pp 1478-1485, issn 0090-9556, 8 p.Article

BCRP/ABCG2 confers anticancer drug resistance without covalent dimerizationSHIGETA, Junichi; KATAYAMA, Kazuhiro; MITSUHASHI, Junko et al.Cancer science. 2010, Vol 101, Num 8, pp 1813-1821, issn 1347-9032, 9 p.Article

Complex Pharmacokinetic Behavior of Ezetimibe Depends on Abcc2, Abcc3, and Abcg2DE WAART, Dirk R; VLAMING, Maria L. H; KUNNE, Cindy et al.Drug metabolism and disposition. 2009, Vol 37, Num 8, pp 1698-1702, issn 0090-9556, 5 p.Article

Oligomerization domain of the multidrug resistance-associated transporter ABCG2 and its dominant inhibitory activityJUNKANG XU; HUI PENG; QUN CHEN et al.Cancer research (Baltimore). 2007, Vol 67, Num 9, pp 4373-4381, issn 0008-5472, 9 p.Article

Breast Cancer Resistance Protein Interacts with Various Compounds in Vitro, but Plays a Minor Role in Substrate Efflux at the Blood-Brain BarrierRONG ZHAO; RAUB, Thomas J; SAWADA, Geri A et al.Drug metabolism and disposition. 2009, Vol 37, Num 6, pp 1251-1258, issn 0090-9556, 8 p.Article

Functionally Overlapping Roles of Abcg2 (Bcrp1) and Abcc2 (Mrp2) in the Elimination of Methotrexate and Its MainToxic Metabolite 7-Hydroxymethotrexate In vivoVLAMING, Maria L. H; PALA, Zeliha; VAN ESCH, Anita et al.Clinical cancer research (Print). 2009, Vol 15, Num 9, pp 3084-3093, issn 1078-0432, 10 p.Article

Substrate-Dependent Breast Cancer Resistance Protein (Bcrp1/Abcg2)-Mediated Interactions : Consideration of Multiple Binding Sites in in Vitro Assay DesignGIRI, Nagdeep; AGARWAL, Sagar; SHAIK, Naveed et al.Drug metabolism and disposition. 2009, Vol 37, Num 3, pp 560-570, issn 0090-9556, 11 p.Article

Dual mTORC1 and mTORC2 inhibitor Palomid 529 penetrates the Blood―Brain Barrier without restriction by ABCB1 and ABCG2FAN LIN; BUIL, Levi; SHERRIS, David et al.International journal of cancer (Print). 2013, Vol 133, Num 5, pp 1222-1233, issn 0020-7136, 12 p.Article

Silencing the Breast Cancer Resistance Protein Expression and Function in Caco-2 Cells Using Lentiviral Vector-Based Short Hairpin RNAWEI ZHANG; JIBIN LI; ALLEN, Samantha M et al.Drug metabolism and disposition. 2009, Vol 37, Num 4, pp 737-744, issn 0090-9556, 8 p.Article

Inhibition of P-glycoprotein (ABCB1)-and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1®ROBEY, Robert W; SHUKLA, Suneet; FINLEY, Elizabeth M et al.Biochemical pharmacology. 2008, Vol 75, Num 6, pp 1302-1312, issn 0006-2952, 11 p.Article

Analysis of ABCG2 expression and side population identifies intrinsic drug efflux in the HCC cell line MHCC-97L and its modulation by Akt signalingCHEN HU; HONG LI; JINJUN LI et al.Carcinogenesis (New York. Print). 2008, Vol 29, Num 12, pp 2289-2297, issn 0143-3334, 9 p.Article

Breast Cancer Resistance Protein 1 Limits Fetal Distribution of Nitrofurantoin in the Pregnant MouseYI ZHANG; HONGGANG WANG; UNADKAT, Jashvant D et al.Drug metabolism and disposition. 2007, Vol 35, Num 12, pp 2154-2158, issn 0090-9556, 5 p.Article

Altered hepatobiliary disposition of 5 (and 6)-carboxy-2',7'-dichlorofluorescein in Abcg2 (Bcrp1) and Abcc2 (Mrp2) knockout miceNEZASA, Ken-Ichi; XIANBIN TIAN; ZAMEK-GLISZCZYNSKI, Maciej J et al.Drug metabolism and disposition. 2006, Vol 34, Num 4, pp 718-723, issn 0090-9556, 6 p.Article

Epidermal growth factor-mediated activation of the map kinase cascade results in altered expression and function of ABCG2 (BCRP)MEYER ZU SCHWABEDISSEN, Henriette E; GRUBE, Markus; DREISBACH, Annette et al.Drug metabolism and disposition. 2006, Vol 34, Num 4, pp 524-533, issn 0090-9556, 10 p.Article

  • Page / 10